Beuger M, Tommasello A, Schwartz R, Clinton M
Department of Psychiatry, University of Maryland, Baltimore 21201-1180, USA.
J Subst Abuse Treat. 1998 Nov-Dec;15(6):589-93. doi: 10.1016/s0740-5472(97)00309-7.
Forty-eight consecutive applicants and 30 known clonidine-abusing methadone patients at three methadone treatment programs were surveyed regarding their use of clonidine. Two distinct patterns of clonidine use emerged. Of 22 applicants who took clonidine illicitly, 15 used it primarily to decrease opioid withdrawal, as well as for its sedating effect. Applicants mostly obtained it from physicians, used an average dose of 0.37 mg at a time, and about one third believed clonidine to be addictive. In contrast, clonidine-using patients took clonidine primarily for its psychoactive effects, including the interaction with methadone, in addition to decreasing opioid withdrawal. Patients obtained clonidine frequently on the street and from family or friends, but less from physicians. The average reported dose for patients was 0.6 mg. The vast majority of these patients felt clonidine was addictive. Our findings, when coupled with the risk inherent in clonidine overdose, suggest that further research into the identification and treatment of clonidine abuse among methadone patients is warranted.
对三个美沙酮治疗项目中的48名连续申请者和30名已知滥用可乐定的美沙酮患者进行了关于他们使用可乐定情况的调查。出现了两种不同的可乐定使用模式。在22名非法服用可乐定的申请者中,15人主要将其用于减轻阿片类药物戒断反应以及利用其镇静作用。申请者大多从医生处获取可乐定,每次平均用量为0.37毫克,约三分之一的人认为可乐定会上瘾。相比之下,使用可乐定的患者服用可乐定主要是为了其精神活性作用,包括与美沙酮的相互作用,此外还用于减轻阿片类药物戒断反应。患者经常从街头以及家人或朋友处获得可乐定,但从医生处获得的较少。患者报告的平均用量为0.6毫克。这些患者中的绝大多数人认为可乐定会上瘾。我们的研究结果,再加上可乐定过量存在的风险,表明有必要对美沙酮患者中可乐定滥用的识别和治疗进行进一步研究。